Skip to content

First Experimental Study of Transference-Interpretations (FEST)

First Experimental Study of Transference Interpretations (FEST)

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00423462
Enrollment
100
Registered
2007-01-18
Start date
1993-01-31
Completion date
2005-12-31
Last updated
2007-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Mood Disorders, Personality Disorders

Keywords

Psychotherapy, Long-term effects

Brief summary

Analysis of the ongoing patient-therapist interaction, the transference, is considered a key active ingredient in psychoanalytically oriented psychotherapy and psychoanalysis.However, one century after Sigmund Freuds's famous Dora case, the first clinical description of transference, no study of transference interpretations have been published.In the present study 100 out-patients were randomized to receive one year weekly dynamic psychotherapy, with and without transference interpretations. That is, one treatment component,transference interpretations, were added to a comparison condition, therapy of the same format, by the same therapists, but without use of transference interpretation. All treatment session were audiotaped, and treatment integrity have been carefully checked. Patients were evaluated at treatment termination, one year after treatment termination and three years after treatment termination. Enrollment of patients started january 1993, and all follow-up evaluations completed by December 2005.

Detailed description

This study is designed to measure specific long-term effects of transference interpretations in dynamic psychotherapy, using an experimental dismantling design. One hundred psychiatric out-patients, referred to seven study therapists, to receive exploratory dynamic psychotherapy, were randomized to one year weekly dynamic psychotherapy, with and without transference interpretations.They suffered from mood,anxiety,and personality disorders or interpersonal problems not due to a mental disorder. All treatment sessions were audiotaped and treatment integrity carefully checked.All patients have been evaluated before treatment, after treatment, one year after termination of treatment, and three years after termination of treatment. The main outcome measures were the Psychodynamic Functioning Scales (PFS) and Inventory of Interpersonal Problems-Circumplex version (IIP-C).Chang over time is assessed using linear mixed model analyses. The main hypothesis is that patients treated with transference interpretations will have a more favourable course over the whole study period of four years. The second hypothesis is that suitable patients, that is patients with a life long pattern of more mature object relations (QOR) and/or patients without comorbid personality disorders will do better with transference interpretations. Insight and identification with the therapist will be analyzed as putative mediators of long-term change in interpersonal functioning

Interventions

BEHAVIORALBrief dynamic psychotherapy

Sponsors

The Research Council of Norway
CollaboratorOTHER
University of Oslo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age 20 - 60 years * Diagnoses Mood-disorder, non-psychotic * Anxiety disorders * Personality disorders * Interpersonal problems not due to a mental disorder

Exclusion criteria

* Psychotic disorders * Bipolar disorder * Organic brain disorder * Substance abuse * Long-term (years) disability * Mental retardation

Design outcomes

Primary

MeasureTime frame
The Psychodynamic Functioning Scales (PFS), clinician rated
Inventory if Interpersonal Problems-Circumplex version (IIP-C), self-report

Secondary

MeasureTime frame
The Global Assessment of Functioning Scale (GAF)
Global Severity Index (GSI) from SCL-90-R

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026